Andy Chevigné and his group, RTI-5152-12 is postulated to raise the amounts of opioid peptides that bind to classical opioid receptors while in the Mind, resulting in heightened painkilling exercise. The LIH-RTI investigation teams proven a collaboration agreement and filed a joint patent